3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Suspended
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
16
Leukemia, Lymphocytic, Chronic, B-Cell
13
Lymphoma, Non-Hodgkin
10
Lymphoma
9
Multiple Myeloma
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Leukemia
8
Recurrence
6
Hodgkin Disease
6
Myeloproliferative Disorders
5
Lymphoma, Mantle-Cell
5
Lymphoma, B-Cell
5
Leukemia, Biphenotypic, Acute
5
Neoplasms
4
Neoplasm, Residual
4
Melanoma
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Follicular
4
Leukemia, Myelomonocytic, Juvenile
4
Leukemia, Lymphoid
4
Immunoproliferative Disorders
4
Immune System Diseases
4
Burkitt Lymphoma
4
Precancerous Conditions
3
Lymphoproliferative Disorders
3
Lymphoma, B-Cell, Marginal Zone
3
Lymphatic Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Interventions
X-Rays
4
Phantoms, Imaging
4
Nuclear Medicine Department, Hospital
4
Magnetic Resonance Spectroscopy
4
regorafenib
3
Specimen Handling
3
Nivolumab
3
Cyclophosphamide
3
Biopsy
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
pembrolizumab
2
olaparib
2
larotrectinib
2
ivosidenib
2
fludarabine
2
ensartinib
2
cabozantinib
2
Etoposide
2
Docetaxel
2
tocilizumab
1
tazemetostat
1
poly ICLC
1
palbociclib
1
naxitamab
1
mifamurtide
1
humanized 3F8 anti-GD2 monoclonal antibody
1
glucarpidase
1
gamma-Glutamyl Hydrolase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Osteosarcoma
×
fludarabine phosphate
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled